MAXTRA (Chlorpheniramine Maleate (2mg/5ml) + Phenylephrine (5mg/5ml))

Maxtra Oral Drops is a formulation designed to alleviate symptoms associated with the common cold in pediatric patients. This medication aims to ease the discomfort that children may experience due to a runny or congested nose, as well as sneezing, thereby facilitating easier breathing and an overall improved sense of well-being. Administration of Maxtra Oral Drops can be done with or without food, and it is crucial to adhere to the specific dosage and duration directed by a healthcare professional. The appropriate dosage will vary based on factors such as the child’s age, weight, and the intensity of the symptoms being treated. It is important not to discontinue the medication prematurely, even if the child appears to be recovering, unless instructed by a physician. Staying well-hydrated during the treatment is essential. Parents or guardians should monitor for any unusual reactions or side effects, and if any concerns arise regarding the child’s response to the treatment, they should seek medical advice without delay. Additionally, special care should be taken if the child has a history of any liver or kidney issues, as these circumstances may necessitate dosage adjustments. Notably, per the guidelines from health authorities, Maxtra Oral Drops are not recommended for children under the age of four.